Lantheus Medical Imaging will receive $300,000 Massachusetts-Israel Innovation Partnership (MIIP) grant, upon signing a collaboration agreement with Check-Cap.
The grant will be used by the companies to develop and manufacture new 3-D Imaging Capsule to screen for polyps and lesions associated with colorectal cancer.
Check-Cap chief executive officer Guy Neev said despite being 90% curable with early detection, colon cancer remains the second-most deadly cancer in the western world.
"Our unique imaging capsule may increase colorectal screening compliance without compromising screening accuracy, and has the potential to reduce the high patient mortality associated with this disease," Neev added.
MIIP, a collaboration between the State of Israel and Commonwealth of Massachusetts, supports entrepreneurship between Massachusetts' and Israel's life sciences, clean energy and technology sectors.
